PRESERVE-006: ONC-392 plus Pluvicto in ARTA resistant mCRPC

Clinical Trial Grant

Duke Scholars

Principal Investigator Andrew John Armstrong Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

OncoC4

Start Date

January 30, 2024

End Date

December 31, 2028

Administered By

Duke Cancer Institute

Awarded By

OncoC4

Start Date

January 30, 2024

End Date

December 31, 2028